U.S. Hospital and Nursing Home Probiotics Market Size, Share & Trends Analysis Report By Channel (Hospitals, Nursing Homes), By Function (Gut Health, Immunity, Wellness), And Segment Forecasts, 2018 - 2025

Published: Mar, 2018 | Pages: 112 | Publisher: Grand View Research
Industry: Food & Beverages | Report Format: Electronic (PDF)

The U.S. hospital & nursing homes probiotics market size is expected to reach USD 203.7 million in 2025, according to a study conducted by Grand View Research, Inc., and is projected to expand at a healthy CAGR of 9.3% over the forecast period. Growth in use of probiotics in healthcare institutions has created various new applications for the product, which is contributing toward development of this market.

Rising demand for natural and healthy products is encouraging manufacturers to include probiotics in their products, which is projected to propel demand in the coming years. Manufacturers are also currently involved in overall market development by creating awareness about the advantages of probiotics. For this purpose, they prefer a collaborative approach by entering into long-term partnerships with probiotic strain suppliers.

In U.S., the ratio of community hospital capacity per 1,000 residents was 2.5 beds per individual in 2014, while the average duration of stay was 5.5 days per hospital stay. Hospital care has witnessed substantial changes over the past four decades. This transformation can be attributed to several factors such as reform in payment systems, modification in practice patterns, shift in consumer preferences, and technological advancements in medical care.

In U.S., rural residents are facing more health problems than urban citizens. Some of the major factors behind poorer healthcare conditions in rural areas in the country are social and cultural differences, economic factors, and educational shortcomings. However, the rural segment is projected to witness the fastest growth rate over coming years owing to presence of various untapped markets, which is attracting healthcare institutions to open or expand their operational and distribution facilities.

Key findings from the report suggest:

• The U.S. hospital & nursing home probiotic market is projected to reach USD 203.7 million by 2025 at an estimated CAGR of 9.3% from 2017 to 2025

• In 2015, private health insurance emerged as the largest contributor to the overall national health expenditure in U.S.

• The share of the rural population reporting fair to poor physical health is nearly one and a half times the percentage of urban residents

• Lucrative opportunities in U.S. are bound to attract new entrants. However, massive investments required for carrying out R&D operations is a cause for concern for new entrants

• Some of the key companies present in the market are Bio-K Plus International Inc.; Probi AB; Procter & Gamble; NutraScience Labs; and Probium LLC.

 Table of Contents

Chapter 1 Methodology and Scope
                1.1 Research methodology
                1.2 Research scope and assumptions
                1.3 List of data sources
Chapter 2 Executive Summary
                2.1 U.S. Hospital & Nursing Home Probiotics: Industry snapshot
Chapter 3 Market Variables Trends and Scope
                3.1 Market segmentation
                3.2 Market size and growth prospects 2014 - 2025
                3.3 U.S. Hospital & Nursing Home Probiotics value chain analysis
                3.4 U.S. Hospital & Nursing Home Probiotics market dynamics
                    3.4.1 Market driver analysis
                        3.4.1.1 Growing inclination towards preventive healthcare
                        3.4.1.2 Development of efficient probiotic strains
                    3.4.2 Market restraint analysis
                        3.4.2.1 High product development costs and stringent government regulations
                        3.4.2.2 Lack of awareness regarding efficacy and usage of probiotics
                3.5 Industry analysis - Porter's
                    3.5.1 Probiotics ingredients industry
                    3.5.2 Probiotics dietary supplements market
                    3.5.3 U.S. Hospital & Nursing Homes Probiotics Market: - 
                3.6 U.S. Hospital & Nursing Home Probiotics PESTEL analysis
Chapter 4 U.S. Hospital & Nursing Homes Probiotics Market: Channel Estimates & Trend Analysis
                4.1 U.S. Hospital & Nursing Homes Probiotics Market share by channel 2017 & 2025
                4.2 Distribution Channel
                    4.2.1 U.S. Hospital & Nursing Homes Probiotics Market Estimates & Forecasts By Distribution Channel 2014 - 2025 (USD Million)
                    4.2.2 Hospitals
                        4.2.2.1 U.S. Hospital Probiotics Market estimates and forecast by number of beds 2014 - 2025 (USD Million)
                        4.2.2.2 U.S. Hospital Probiotics Market estimates and forecast by payers 2014 - 2025 (USD Million)
                        4.2.2.3 U.S. Hospital Probiotics Market estimates and forecast by location 2014 - 2025 (USD Million)
                    4.2.3 Nursing Homes
                        4.2.3.1 U.S. nursing homes probiotics market estimates and forecast by number of beds 2014 - 2025 (USD Million)
                        4.2.3.2 U.S. nursing homes probiotics market estimates and forecast by payers 2014 - 2025 (USD Million)
                        4.2.3.3 U.S. nursing homes probiotics market estimates and forecast by ownership 2014 - 2025 (USD Million)
Chapter 5 U.S. Hospital & Nursing Homes Probiotics Market: Function Estimates & Trend Analysis
                5.1 U.S. Hospital & Nursing Homes Probiotics Market share by function 2017 & 2025
                    5.1.1 U.S. Hospital Probiotics Market estimates and forecast by function 2014 - 2025 (USD Million)
Chapter 6 Competitive Landscape
                6.1 Heat Map Analysis
                6.2 Dietary Supplements - Competitive Mapping
                    6.2.1 Culturelle Probiotics
                        6.2.1.1 Product Purity
                        6.2.1.2 Nutritional Value
                        6.2.1.3 Ingredient Safety
                        6.2.1.4 Projected Efficacy
                    6.2.2 Pinnacle Nutrition Advanced Formula Complete
                        6.2.2.1 Label Accuracy
                        6.2.2.2 Projected Efficacy
                    6.2.3 MegaFood MegaFlora
                        6.2.3.1 Label Accuracy
                        6.2.3.2 Projected Efficacy
                    6.2.4 Hyperbiotics PRO - 15 Advanced Strength
                        6.2.4.1 Ingredient Safety
                        6.2.4.2 Projected Efficacy
                    6.2.5 Dr. Mercola Complete Probiotics
                        6.2.5.1 Label Accuracy
                        6.2.5.2 Projected Efficacy
                    6.2.6 Origin Essentials Best Probiotic
                        6.2.6.1 Label Accuracy
                        6.2.6.2 Projected Efficacy
                    6.2.7 Schiff Digestive Advantage Daily Probiotic
                        6.2.7.1 Label Accuracy
                        6.2.7.2 Projected Efficacy
                    6.2.8 Trunature Digestive Probiotic
                        6.2.8.1 Label Accuracy
                        6.2.8.2 Projected Efficacy
                    6.2.9 Ortho Molecular Products Ortho Biotic
                        6.2.9.1 Label Accuracy
                        6.2.9.2 Projected Efficacy
                    6.2.10 Garden Of Life Primal Defense Ultra Probiotic Formula
                        6.2.10.1 Label Accuracy
                        6.2.10.2 Projected Efficacy
                    6.2.11 Florastor
                        6.2.11.1 Label Accuracy
                        6.2.11.2 Projected Efficacy
                    6.2.12 Dr. Formulas Nexabiotic Advanced Multi - Probiotic
                        6.2.12.1 Label Accuracy
                        6.2.12.2 Projected Efficacy
                    6.2.13 Align Probiotic Supplement
                        6.2.13.1 Label Accuracy
                        6.2.13.2 Projected Efficacy
                    6.2.14 Healthy Origins Probiotic
                        6.2.14.1 Label Accuracy
                        6.2.14.2 Projected Efficacy
                    6.2.15 Rephresh Pro - B Probiotic Feminine Supplement
                        6.2.15.1 Label Accuracy
                        6.2.15.2 Projected Efficacy
                6.3 Estimated Company Market Share
                6.4 Vendor Landscape
Chapter 7 Company Profiles
                7.1 Bio - K Plus International Inc.
                    7.1.1 Company overview
                    7.1.2 Product benchmarking
                7.2 American Lifeline Inc.
                    7.2.1 Company overview
                    7.2.2 Product benchmarking
                7.3 Rising Pharmaceuticals Inc.
                    7.3.1 Company overview
                    7.3.2 Product benchmarking
                7.4 Becton Dickinson and Company
                    7.4.1 Company overview
                    7.4.2 Financial performance
                    7.4.3 Product benchmarking
                    7.4.4 Strategic initiatives
                7.5 Procter & Gamble
                    7.5.1 Company overview
                    7.5.2 Financial performance
                    7.5.3 Product benchmarking
                7.6 NutraScience Labs
                    7.6.1 Company overview
                    7.6.2 Product benchmarking
                    7.6.3 Strategic initiatives
                7.7 Vitakem Nutraceuticals Inc.
                    7.7.1 Company overview
                    7.7.2 Product benchmarking
                7.8 Probium LLC
                    7.8.1 Company overview
                    7.8.2 Product benchmarking
                    7.8.3 Strategic initiatives
                7.9 Protexin
                    7.9.1 Company overview
                    7.9.2 Product benchmarking
                    7.9.3 Strategic initiatives
                7.10 Nutraceutix
                    7.10.1 Company overview
                    7.10.2 Financial performance
                    7.10.3 Product benchmarking
                    7.10.4 Strategic Initiatives
               7.11 Nebraska Cultures
                    7.11.1 Company overview
                    7.11.2 Product benchmarking
                7.12 Mercola
                    7.12.1 Company overview
                    7.12.2 Product benchmarking
                7.13 Contract NUTRA
                    7.13.1 Company overview
                    7.13.2 Product benchmarking
                7.14 UP4 Probiotics LLC
                    7.14.1 Company overview
                    7.14.2 Product benchmarking
                7.15 Amerifit Brands
                    7.15.1 Company overview
                    7.15.2 Product benchmarking
                7.16 UAS Laboratories
                    7.16.1 Company overview
                    7.16.2 Product benchmarking
                7.17 Probiotical S.p.A
                    7.17.1 Company overview
                    7.17.2 Product benchmarking
                7.18 Ganeden Inc.
                    7.18.1 Company overview
                    7.18.2 Product benchmarking
                7.19 Biocodex Inc.
                    7.19.1 Company overview
                    7.19.2 Product benchmarking
                    7.19.3 Strategic initiatives
                7.20 Chr. Hansen Holding A/S
                    7.20.1 Company overview
                    7.20.2 Financial performance
                    7.20.3 Product benchmarking
                    7.20.4 Strategic initiatives
                7.21 DuPont Nutrition & Health
                    7.21.1 Company overview
                    7.21.2 Product benchmarking
                    7.21.3 Strategic initiatives
                7.22 Lallemand Inc.
                    7.22.1 Company overview
                    7.22.2 Product benchmarking
                7.23 Probi AB
                    7.23.1 Company overview
                    7.23.2 Financial performance
                    7.23.3 Product benchmarking
                    7.23.4 Strategic initiatives

List of Tables

TABLE 1 Factors determining the capability of commercial probiotic cultures to survive stress conditions in drug/food production or in the gastrointestinal tract (GIT)
TABLE 2 U.S. hospital & nursing home probiotics-Key market drivers impact
TABLE 3 Leading probiotic ingredients by category (January 2011 to October 2016)
TABLE 4 List of probiotic products that are commercially available probiotic culture composition and their applications
TABLE 5 U.S. Hospital & Nursing Home Probiotics Market-Key market restraints impact
TABLE 6 U.S. Hospital & Nursing Homes Probiotics Market Estimates & Forecasts By Distribution Channel 2014 - 2025 (USD Million)
TABLE 7 U.S. Hospital Probiotics Market estimates and forecast by number of beds 2014 - 2025 (USD Million)
TABLE 8 U.S. Hospital Probiotics Market estimates and forecast by payers 2014 - 2025 (USD Million)
TABLE 9 U.S. Hospital Probiotics Market estimates and forecast by location 2014 - 2025 (USD Million)
TABLE 10 U.S. nursing homes probiotics market estimates and forecast by number of beds 2014 - 2025 (USD Million)
TABLE 11 U.S. nursing homes probiotics market estimates and forecast by payers 2014 - 2025 (USD Million)
TABLE 12 U.S. nursing homes probiotics market estimates and forecast by ownership 2014 - 2025 (USD Million)
TABLE 13 U.S. Hospital Probiotics Market estimates and forecast by function 2014 - 2025 (USD Million)
TABLE 14 Applications of probiotics and supplements for different age group

List of Figures

FIG. 1 U.S. Hospital & Nursing Home Probiotics market volume share, by type 2016 & 2025 (USD Million)
FIG. 2 U.S. Hospital & Nursing Home Probiotics: Industry snapshot
FIG. 3 U.S. Hospital & Nursing Home Probiotics market segmentation
FIG. 4 U.S. Hospital & Nursing Home Probiotics market, by revenue (USD Million), 2014 - 2025
FIG. 5 Community hospital beds (U.S.) - Selected years 1975 - 2014
FIG. 6 Average length of stay rate (U.S.) - Selected years 1975 - 2014
FIG. 7 Average occupancy rate (U.S.) - Selected years 1975 - 2014
FIG. 8 Nursing home beds rate (U.S.) - Selected years 1977-2014
FIG. 9 Residents rate (U.S.) - Selected years 1977 to 2014
FIG. 10 Average occupancy rate: Selected years 1977-2014
FIG. 11 Personal healthcare expenditure, by source of funds (U.S.) - 1975, 1995, 2015
FIG. 12 Personal healthcare expenditure, by expenditure type (U.S.) - 1975, 1995, 2015
FIG. 13 U.S. hospital & nursing home probiotics value chain analysis
FIG. 14 The sequential steps from probiotic selection to its application in final products
FIG. 15 U.S. Hospital & Nursing Home Probiotics market dynamics
FIG. 16 Per capita expenditure on probiotics, by country, 2014-2015 (USD/person)
FIG. 17 Steps involved in process development and commercial production of probiotics
FIG. 18 U.S. Hospitals & Nursing Home Probiotics Porter's analysis
FIG. 19 U.S. Hospital & Nursing Home Probiotics PESTEL analysis
FIG. 20 U.S. Hospital & Nursing Homes Probiotics by channel, 2017 & 2025
FIG. 21 Projected hospital care expenditures by source of funds, 2017-2025 (USD Billions)
FIG. 22 U.S. Hospital & Nursing Homes Probiotics by channel, 2017 & 2025